| 00:19 | Oxurion Issues EUR 2.8 million in Bonds for Tranche 1 (A) of Funding Program with Atlas.. |  |
| 00:18 | Oxurion Issues EUR 2.8 million in Bonds for Tranche 1 (A) of Funding Program with Atlas.. | |
| 15/03 | Oxurion NV Announces Board Changes | |
| 15/03 | Oxurion NV Provides Update on Recruitment for Kalahari Phase 2, Part B Trial of Novel P.. | |
| 14/03 | Oxurion Provides Update on Recruitment for KALAHARI Phase 2, Part B Trial of Novel PKal.. | |
| 14/03 | Oxurion Provides Update on Recruitment for KALAHARI Phase 2, Part B Trial of Novel PKal.. | |
| 09/03 | Oxurion Receives Transparency Notification from Negma Group | |
| 09/03 | Oxurion Receives Transparency Notification from Negma Group | |
| 02/03 | Oxurion Receives Transparency Notification from Negma Group | |
| 02/03 | Oxurion Receives Transparency Notification from Negma Group | |
| 02/03 | Funding Program between Oxurion and Negma Ends | |
| 02/03 | Oxurion Announces Subscription Agreement with Atlas Providing the Company with Up To €2.. | |
| 02/03 | Oxurion Announces Subscription Agreement with Atlas Providing the Company with Up To €2.. | |
| 02/03 | Funding Program between Oxurion and Negma Ends | |
| 02/03 | Oxurion NV announced that it expects to receive €20.8 million in funding | |
| 02/03 | Oxurion NV announced that it has received €15 million in funding from Negma Group .. | |
| 24/02 | Oxurion Receives Transparency Notifications from Negma Group | |
| 24/02 | Oxurion Receives Transparency Notifications from Negma Group | |
| 17/02 | Oxurion Receives Transparency Notifications from Negma Group | |
| 17/02 | Oxurion Receives Transparency Notifications from Negma Group | |
| 10/02 | Oxurion Receives Transparency Notifications | |
| 10/02 | Oxurion Receives Transparency Notifications | |
| 03/02 | Oxurion Receives Transparency Notifications from Negma Group | |
| 03/02 | Oxurion Receives Transparency Notifications from Negma Group | |
| 30/01 | Oxurion Provides Further Details Concerning the Second Amendment to Negma Funding Progr.. | |
| 27/01 | Oxurion Provides Further Details Concerning the Second Amendment to Negma Funding Progr.. | |
| 27/01 | Oxurion Provides Further Details Concerning the Second Amendment to Negma Funding Progr.. | |
| 25/01 | Oxurion Announces Second Amendment to Negma Funding Program | |
| 2022 | Oxurion Announces the Continuation of KALAHARI Phase 2, Part B Study in Diabetic Macula.. | |
| 2022 | Oxurion Announces the Continuation of KALAHARI Phase 2, Part B Study in Diabetic Macula.. | |
| 2022 | Oxurion NV Announces the Continuation of KALAHARI Phase 2, Part B Study in Diabetic Mac.. | |
| 2022 | Oxurion Further Improves THR-149 Patent Position | |
| 2022 | Oxurion Further Improves THR-149 Patent Position | |
| 2022 | Oxurion Announces Interim Analysis for KALAHARI Trial | |
| 2022 | Oxurion Announces Interim Analysis for KALAHARI Trial | |
| 2022 | Oxurion NV Announces Interim Analysis for KALAHARI Trial | |
| 2022 | Oxurion Receives Transparency Notifications Based on New Denominator | |
| 2022 | Oxurion Receives Transparency Notifications Based on New Denominator | |
| 2022 | Oxurion : Supplement to the Prospectus of 30 August 2022 | |
| 2022 | Oxurion Receives Transparency Notification from Fidelity Management & Research Company .. | |
| 2022 | Oxurion Receives Transparency Notification from Fidelity Management & Research Company .. | |
| 2022 | Oxurion To Participate in Upcoming Investor Conferences | |
| 2022 | Oxurion To Participate in Upcoming Investor Conferences | |
| 2022 | Oxurion To Participate in Upcoming Scientific and Investor Conferences | |
| 2022 | Oxurion To Participate in Upcoming Scientific and Investor Conferences | |
| 2022 | Oxurion Publishes First Half 2022 Results | |
| 2022 | Oxurion Publishes First Half 2022 Results | |
| 2022 | Oxurion : Prospectus for the admission to trading on Euronext Brussels of up to 30,500,000.. | |
| 2022 | Oxurion NV Reports Earnings Results for the Half Year Ended June 30, 2022 | |
| 2022 | Oxurion : Special report of the Board of Directors | |
| 2022 | Oxurion Announces Amendment to Funding Program with Negma Group for EUR 6 Million in .. | |
| 2022 | Oxurion Announces Amendment to Funding Program with Negma Group for EUR 6 Million in .. | |
| 2022 | Oxurion To Present at Upcoming Scientific and Investor Conferences | |
| 2022 | Oxurion To Present at Upcoming Scientific and Investor Conferences | |
| 2022 | Oxurion : Prospectus for the admission to trading on Euronext Brussels of up to 15,651,259.. | |
| 2022 | Oxurion Announces Presentations at Upcoming Scientific and Investor Conferences | |
| 2022 | Oxurion Announces Presentations at Upcoming Scientific and Investor Conferences | |
| 2022 | Oxurion Announces Two Presentations at The Macula Society 45th Annual Meeting | |
| 2022 | Oxurion Announces Two Presentations at The Macula Society 45th Annual Meeting | |
| 2022 | Oxurion Announces Two Presentations at The Macula Society 45th Annual Meeting | |
| 2022 | Oxurion Announces Preclinical Presentation on THR-149 at KININ2022 | |
| 2022 | Oxurion Announces Preclinical Presentation on THR-149 at KININ2022 | |
| 2022 | Oxurion Announces Preclinical Presentation on THR-149 at KININ2022 | |
| 2022 | Oxurion NV Announces Preclinical Presentation on THR-149 at KININ2022 | |
| 2022 | Oxurion Announces Two Upcoming Presentations at The Macula Society 45th Annual Meeting | |
| 2022 | Oxurion Announces Two Upcoming Presentations at The Macula Society 45th Annual Meeting | |
| 2022 | Oxurion Announces Two Upcoming Presentations at The Macula Society 45th Annual Meeting | |
| 2022 | Oxurion to Participate in Upcoming Investor Conferences | |
| 2022 | Oxurion to Participate in Upcoming Investor Conferences | |
| 2022 | Oxurion Announces Results of the Extraordinary Shareholders' Meeting held on 24 May 202.. | |
| 2022 | Oxurion Announces Results of the Extraordinary Shareholders' Meeting held on 24 May 202.. | |
| 2022 | Oxurion Announces Results of the Extraordinary Shareholders' Meeting held on 24 May 202.. | |
| 2022 | Oxurion Announces Upcoming Preclinical Presentation on THR-149 at KININ2022 | |
| 2022 | Oxurion Announces Upcoming Preclinical Presentation on THR-149 at KININ2022 | |
| 2022 | Oxurion Announces Upcoming Preclinical Presentation on THR-149 at KININ2022 | |
| 2022 | Oxurion Announces Results of the Extraordinary and Annual Shareholders' Meetings of 3 M.. | |
| 2022 | Oxurion Announces Top-Line Results from Part A of Phase 2 INTEGRAL Trial Evaluating THR.. | |
| 2022 | Oxurion Announces Top-Line Results from Part A of Phase 2 INTEGRAL Trial Evaluating THR.. | |
| 2022 | Oxurion Announces Top-Line Results from Part A of Phase 2 INTEGRAL Trial Evaluating THR.. | |
| 2022 | Oxurion to Participate in Upcoming Conferences | |
| 2022 | Oxurion Announces Upcoming Pre-Clinical Data Presentation on THR-687 for the Treatment .. | |
| 2022 | Oxurion Announces Upcoming Pre-Clinical Data Presentation on THR-687 for the Treatment .. | |
| 2022 | Oxurion Announces Extraordinary and Annual Shareholders' Meetings | |
| 2022 | Oxurion Announces Extraordinary and Annual Shareholders' Meetings | |
| 2022 | Oxurion Publishes 2021 Annual Report | |
| 2022 | Oxurion : to Participate in Needham Virtual Healthcare Conference28 Mar 2022 | |
| 2022 | Oxurion to Participate in Needham Virtual Healthcare Conference | |
| 2022 | Oxurion to Participate in Needham Virtual Healthcare Conference | |
| 2022 | Oxurion NV Auditor Raises 'Going Concern' Doubt | |
| 2022 | Oxurion Publishes 2021 Annual Report | |
| 2022 | Oxurion : Publishes 2021 Annual Report25 Mar 2022 | |
| 2022 | Oxurion : Receives Transparency Notifications from Fidelity Management & Research Company .. | |
| 2022 | Oxurion Receives Transparency Notifications from Fidelity Management & Research Company.. | |
| 2022 | Oxurion Successfully Closes EUR >10 Million in Private Placement; Led by new top-tier h.. | |
| 2022 | Oxurion Successfully Closes EUR >10 Million in Private Placement | |
| 2022 | Oxurion NV announced that it has received €10.405496 million in funding from Fidel.. | |
| 2022 | Oxurion successfully raises eur >10 million from leading us and european healthcare inv.. | |
| 2022 | Oxurion successfully raises eur >10 million from leading us and european healthcare in.. | |
| 2022 | Oxurion NV announces 2021 Full Year Results and 2022 Outlook | |
| 2022 | Oxurion NV Reports Earnings Results for the Full Year Ended December 31, 2021 | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
